Visit https://www.peervoice.com/AVQ860 to view the entire programme with slides. After completing “Ewa A. Jankowska, MD, PhD - Breakthroughs and Game-Changers in Heart Failure”, participants will be able to: Describe the pathophysiology of heart failure with reduced ejection fracture (HFrEF) and heart failure with preserved ejection fracture (HFpEF); Explain the rationale for SGLT2 inhibition in patients with HFrEF and HFpEF; and Discuss the potential clinical implications of novel strategies for ongoing support of patients with HFrEF and HFpEF.